Paralel Advisors LLC Makes New $1.90 Million Investment in HCA Healthcare, Inc. $HCA

Paralel Advisors LLC acquired a new position in shares of HCA Healthcare, Inc. (NYSE:HCAFree Report) in the 2nd quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The institutional investor acquired 4,883 shares of the company’s stock, valued at approximately $1,904,000.

A number of other large investors have also recently bought and sold shares of HCA. BlackRock Inc. bought a new stake in shares of HCA Healthcare during the 2nd quarter valued at about $5,069,974,000. State Street Corp boosted its holdings in shares of HCA Healthcare by 1.0% during the 4th quarter. State Street Corp now owns 7,566,643 shares of the company’s stock worth $3,532,563,000 after buying an additional 76,039 shares in the last quarter. Capital World Investors lifted its position in shares of HCA Healthcare by 0.8% during the 4th quarter. Capital World Investors now owns 4,999,422 shares of the company’s stock valued at $2,334,040,000 after acquiring an additional 40,086 shares during the period. Wellington Management Group LLP grew its holdings in HCA Healthcare by 20.5% in the second quarter. Wellington Management Group LLP now owns 4,707,473 shares of the company’s stock worth $1,835,397,000 after purchasing an additional 799,761 shares during the period. Finally, Geode Capital Management LLC increased its position in HCA Healthcare by 0.4% in the 4th quarter. Geode Capital Management LLC now owns 3,663,705 shares of the company’s stock valued at $1,702,738,000 after buying an additional 13,565 shares in the last quarter. 62.73% of the stock is currently owned by institutional investors and hedge funds.

Wall Street Analysts Forecast Growth

A number of equities analysts recently issued reports on the company. Weiss Ratings cut HCA Healthcare from a “buy (b-)” rating to a “hold (c+)” rating in a report on Tuesday, June 9th. Wells Fargo & Company boosted their target price on shares of HCA Healthcare from $369.00 to $381.00 and gave the stock an “equal weight” rating in a research report on Monday, August 3rd. Royal Bank Of Canada reissued an “outperform” rating and set a $435.00 price objective on shares of HCA Healthcare in a report on Monday, July 27th. The Goldman Sachs Group cut their target price on HCA Healthcare from $558.00 to $485.00 and set a “buy” rating on the stock in a research report on Tuesday, July 28th. Finally, UBS Group cut their price objective on shares of HCA Healthcare from $635.00 to $579.00 and set a “buy” rating on the stock in a report on Monday, July 27th. Fourteen analysts have rated the stock with a Buy rating, eight have issued a Hold rating and one has given a Sell rating to the company. According to MarketBeat, HCA Healthcare presently has a consensus rating of “Moderate Buy” and an average price target of $462.64.

Check Out Our Latest Stock Report on HCA

HCA Healthcare Stock Down 0.0%

HCA stock opened at $404.95 on Monday. The business has a 50 day moving average of $403.35 and a 200-day moving average of $436.82. The firm has a market cap of $87.67 billion, a PE ratio of 13.56, a P/E/G ratio of 1.33 and a beta of 1.10. HCA Healthcare, Inc. has a 12-month low of $353.99 and a 12-month high of $556.52.

HCA Healthcare (NYSE:HCAGet Free Report) last posted its quarterly earnings data on Friday, July 24th. The company reported $7.59 earnings per share for the quarter, topping the consensus estimate of $7.56 by $0.03. The business had revenue of $20.23 billion for the quarter, compared to analysts’ expectations of $19.76 billion. HCA Healthcare had a negative return on equity of 244.79% and a net margin of 8.77%.The business’s revenue was up 8.7% on a year-over-year basis. During the same quarter in the previous year, the firm earned $6.84 earnings per share. On average, research analysts expect that HCA Healthcare, Inc. will post 29.42 earnings per share for the current year.

HCA Healthcare Announces Dividend

The business also recently disclosed a quarterly dividend, which will be paid on Wednesday, September 30th. Shareholders of record on Wednesday, September 16th will be given a $0.78 dividend. The ex-dividend date of this dividend is Wednesday, September 16th. This represents a $3.12 annualized dividend and a yield of 0.8%. HCA Healthcare’s payout ratio is currently 10.45%.

HCA Healthcare Company Profile

(Free Report)

HCA Healthcare is a for‑profit operator of healthcare facilities headquartered in Nashville, Tennessee. Founded in 1968, the company owns and operates a network of hospitals and related healthcare facilities and has grown through organic expansion and acquisitions to become a large provider of inpatient and outpatient services.

The company’s core activities include the operation of acute care hospitals, freestanding surgical and emergency centers, and outpatient clinics. HCA’s services encompass inpatient care, surgical services, emergency medicine, diagnostic imaging and laboratory testing, and various outpatient and ambulatory care offerings.

Further Reading

Want to see what other hedge funds are holding HCA? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for HCA Healthcare, Inc. (NYSE:HCAFree Report).

Institutional Ownership by Quarter for HCA Healthcare (NYSE:HCA)

Receive News & Ratings for HCA Healthcare Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for HCA Healthcare and related companies with MarketBeat.com's FREE daily email newsletter.